Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA

Rheumatology (United Kingdom)

Volumn 52, Issue 12, 2013, Pages 2223-2228

  Mekinian, Arsène ^a   Nicaise Roland, Pascale ^b   Chollet Martin, Sylvie ^b   Fain, Olivier ^a   Crestani, Bruno ^b  

^a UNIVERSITÉ PARIS 13   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Anti Ro52 60; Diagnosis; Interstitial lung disease; Sjogren's syndrome

Indexed keywords

IMMUNOGLOBULIN; RO 52 ANTIBODY; RO 60 ANTIBODY; RO ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG USE; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME; XEROSTOMIA;

ANTI-RO52/60; DIAGNOSIS; INTERSTITIAL LUNG DISEASE; SJOGREN'S SYNDROME;

AGED; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIGENS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME;

EID: 84887658562     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket295     Document Type: Article

References (16)

1. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
2. Burbelo PD, Ching KH, Issa AT et al. Rapid serological detection of autoantibodies associated with Sjögren's syndrome. J Transl Med 2009;7:83.
3. Damoiseaux J, Boesten K, Giesen J et al. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann N Y Acad Sci 2005;1050:340-7.
4. Peene I, Meheus L, Veys E et al. Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB:the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis 2002;12:1090-4.
5. Ghillani P, André C, Toly C et al. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti- SSA 60 kDa antibodies:results of a multicentric study. Autoimmun Rev 2011;10:509-13.
6. Hervier B, Rimbert M, Colonna F et al. Clinical significance of anti-Ro/SSA-52 kDa antibodies:a retrospective monocentric study. Rheumatology 2009;48:964-7.
7. Retamozo S, Akasbi M, Brito-Zeron P et al. Anti-Ro52 antibody testing influences the classification and clinical characterization of primary Sjögren's syndrome. Clin Exp Rheumatol 2012;30:686-92.
8. Locht H, Pelck R, Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n = 321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev 2005;4:276-81.
9. Song JS, Do JH, Lee SW. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjogren's syndrome. Rheumatol Int 2012;32:491-5.
10. Shiboski SC, Shiboski CH, Criswell L et al. American College of Rheumatology classification criteria for Sjögren's syndrome:a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012;64:475-87.
11. Marie I, Josse S, Decaux O et al. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 2012;11:739-45.
12. Jaeggi E, Laskin C, Hamilton R et al. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibodyexposed fetuses and infants. J Am Coll Cardiol 2010;55:2778-84.
13. Oke V, Wahren-Herlenius M. The immunobiology of Ro52 (TRIM21) in autoimmunity:a critical review. J Autoimmun 2012;39:77-82.
14. Ferreira JP, Almeida I, Marinho A et al. Anti-Ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma. ISRN Rheumatol 2012; 2012:415272.
15. Boitiaux JF, Debray MP, Nicaise-Roland P et al. Idiopathic interstitial lung disease with anti-SSA antibody. Rheumatology 2011;50:2245-50.
16. Langguth DM, Morris S, Clifford L et al. Specific testing for 'isolated' anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value. J Clin Pathol 2007;60:670-3.